Teemu D. Laajala
0000-0002-7016-7354
Publication & Citation Trends
Most Cited Works
Publications
132 total
Abstract B021: Current oncological large language model research lacks reproducibility, transparency, and long term support
Cited by 0
Semantic Scholar
Comparable recurrence risk for MRI‐detected Gleason Grade Group (GG) 2 and systematic biopsy‐detected GG1 prostate cancer
Cited by 0
Semantic Scholar
Abstract B018: Practical benchmarking of large language models for structuring synthetic prostate cancer histopathology statements in English and Finnish
Cited by 0
Semantic Scholar
Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
Cited by 0
Semantic Scholar
NPEPPS Is a Druggable Driver of Platinum Resistance OA
Cited by 8
Semantic Scholar
P7 PI-RADS score 5 as a beacon for Prostate-specific mortality OA
Cited by 0
Semantic Scholar
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer OA
Cited by 16
Semantic Scholar
Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma OA
Cited by 4
Semantic Scholar
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment OA
Cited by 4
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(18)
PARP inhibition in cancer therapy
(17)
Peptidase Inhibition and Analysis
(16)
Bladder and Urothelial Cancer Treatments
(15)
Statistical Methods in Clinical Trials
(15)
Frequent Co-Authors
Affiliations
Åbo Akademi University
University of Helsinki
University of Turku
Turku University of Applied Sciences
University of Pittsburgh